Prognosis in systemic lupus erythematosus
Corresponding Author
John D. Reveille MD
Department of Medicine
Departments of Medicine (Division of Clinical Immunology and Rheumatology and the Clinical Information Systems), Biostatistics and Biomathematics, and Epidemiology, School of Medicine and School of Public Health. The University of Alabama at Birmingham.
Division of Rheumatology and Clinical Immunogenetics, University of Texas Health Science Center, PO Box 20708, Houston, TX 77225Search for more papers by this authorAlfred Bartolucci PhD
Department of Biostatistics and Biomathematics
Departments of Medicine (Division of Clinical Immunology and Rheumatology and the Clinical Information Systems), Biostatistics and Biomathematics, and Epidemiology, School of Medicine and School of Public Health. The University of Alabama at Birmingham.
Search for more papers by this authorGraciela S. Alarcón Md, Mph
Department of Medicine
Departments of Medicine (Division of Clinical Immunology and Rheumatology and the Clinical Information Systems), Biostatistics and Biomathematics, and Epidemiology, School of Medicine and School of Public Health. The University of Alabama at Birmingham.
Search for more papers by this authorCorresponding Author
John D. Reveille MD
Department of Medicine
Departments of Medicine (Division of Clinical Immunology and Rheumatology and the Clinical Information Systems), Biostatistics and Biomathematics, and Epidemiology, School of Medicine and School of Public Health. The University of Alabama at Birmingham.
Division of Rheumatology and Clinical Immunogenetics, University of Texas Health Science Center, PO Box 20708, Houston, TX 77225Search for more papers by this authorAlfred Bartolucci PhD
Department of Biostatistics and Biomathematics
Departments of Medicine (Division of Clinical Immunology and Rheumatology and the Clinical Information Systems), Biostatistics and Biomathematics, and Epidemiology, School of Medicine and School of Public Health. The University of Alabama at Birmingham.
Search for more papers by this authorGraciela S. Alarcón Md, Mph
Department of Medicine
Departments of Medicine (Division of Clinical Immunology and Rheumatology and the Clinical Information Systems), Biostatistics and Biomathematics, and Epidemiology, School of Medicine and School of Public Health. The University of Alabama at Birmingham.
Search for more papers by this authorAbstract
To assess the impact of demographic and clinical factors on prognosis in patients with systemic lupus erythematosus (SLE), we examined survivorship by life-table analysis in 389 patients. There were approximately equal numbers of Caucasian patients and American black patients in this study group. On both univariate and multivariate analyses, we found that both American black race and increasing age at SLE onset independently worsened the probability of survival. Of all the clinical factors we analyzed, thrombocytopenia emerged as the only independent risk factor for a worse prognosis in SLE. In all clinical and demographic groups considered, the leading cause of death was infection.
References
- 1 Merrell M, Shulman LE: Determination of prognosis in chronic disease, illustrated by systemic lupus erythema-tosus. J Chronic Dis 1: 12–32, 1955
- 2 Rupe CE, Nickel SN: New clinical concepts of systemic lupus erythematosus. JAMA 171: 1055–1061, 1959
- 3 McCombs RP, Patterson JF: Factors influencing the course and prognosis of systemic lupus erythematosus. N Engl J Med 260: 1195–1204, 1959
- 4
Kellum RE,
Haserick JR:
Systemic lupus erythematosus: a statistical evaluation of mortality based on a consecutive series of 299 patients.
Arch Intern Med
113:
92–99,
1964
10.1001/archinte.1964.00280080036008 Google Scholar
- 5 Siegel M, Gwon N, Lee SL, Rivero I, Wong W: Survivorship in systemic lupus erythematosus: relationships to race and pregnancy. Arthritis Rheum 12: 117–125, 1969
- 6 Estes D, Christian C: The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50: 85–95, 1971
- 7 Dubois EL, Wierzchowiecki M, Cox MB, Weiner JM: Duration and death in systemic lupus erythematosus: an analysis of 249 cases. JAMA 227: 1399–1402, 1974
- 8 Fries JF, Weyls S, Holman HR: Estimating prognosis in systemic lupus erythematosus. Am J Med 57: 561–565, 1974
- 9 Fessel WJ: Systemic lupus erythematosus in the community: incidence, prevalence, outcome and first symptoms: the high prevalence in black women. Arch Intern Med 134: 1027–1035, 1974
- 10 Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM, Stevens MB: Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 55: 323–339, 1976
- 11 Lee P, Urowitz MB, Bookman AAM, Koehler BE, Smythe HA, Gordon DA, Ogryzlo MA: Systemic lupus erythematosus: a review of 110 cases with respect to nephritis, the nervous system, infection, aseptic necrosis and prognosis. Q J Med 46: 1–32, 1977
- 12 Grigor R, Edmonds J, Lewkonia R, Bresnihan B, Hughes GRV: Systemic lupus erythematosus: a prospective analysis. Ann Rheum Dis 37: 121–128, 1978
- 13 Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL: Systemic lupus erythematosus—survival patterns: experience with 609 patients. JAMA 246: 934–938, 1981
- 14 Hochberg MC, Dorsch CA, Feinglass EJ, Stevens MB: Survivorship in systemic lupus erythematosus: effect of antibody to extractable nuclear antigen. Arthritis Rheum 24: 54–59, 1981
- 15 Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, Medsger TA Jr, Ziegler G, Klippel JH, Hadler NM, Albert DA, Hess EV, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV: A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 25: 601–611, 1982
- 16 Studenski S, Allen NB, Caldwell DS, Rice JR, Polisson RP: Survival in systemic lupus erythematosus: a multivariate analysis of demographic factors. Arthritis Rheum 30: 1326–1332, 1987
- 17 Ballou SP, Khan MA, Kushner I: Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum 25: 55–60, 1982
- 18 Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB: Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 64: 285–295, 1985
- 19 Masi AT, Kaslow RA: Sex effects in systemic lupus erythematosus: a clue to pathogenesis. Arthritis Rheum 21: 480–484, 1978
- 20 Baker SB, Rovira JR, Campion EW, Mills JA: Late onset systemic lupus erythematosus. Am J Med 66: 727–732, 1979
- 21 Wilson HA, Hamilton ME, Spyker DA, Brunner CM, O'Brien WM, Davis JS IV, Winfield JB: Age influences the clinical and serologic expression of systemic lupus erythematosus. Arthritis Rheum 24: 1230–1235, 1981
- 22 Foad BSI, Sheon RP, Kirsner AB: Systemic lupus erythematosus in the elderly. Arch Intern Med 130: 743–746, 1972
- 23 Dimant J, Ginzler EM, Schlesinger M, Diamond HS: Systemic lupus erythematosus in the older age group: computer analysis. J Am Geriatr Soc 27: 58–61, 1979
- 24 Urowitz MB, Stevens MB, Shulman LE: The influence of age on clinical pattern of systemic lupus erythematosus. Arthritis Rheum 10: 319–320, 1967
- 25 Catoggio LF, Skinner RP, Smith G, Maddison PS: Systemic lupus erythematosus in the elderly: clinical and serological characteristics. J Rheumatol 11: 175–181, 1984
- 26 Abeles M, Urman JD, Weinstein A, Lowenstein M, Rothfield NF: Systemic lupus erythematosus in the younger patient: survival studies. J Rheumatol 7: 515–522, 1980
- 27 Hochberg MC: The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970–1977. Arthritis Rheum 28: 80–86, 1985
- 28 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277, 1982
- 29 Pincus T, Schur PH, Rose JA, Decker JL, Talal N: Measurements of serum DNA-binding activity in SLE. N Engl J Med 281: 701–705, 1969
- 30 Aarden LA, de Groot ER, Feltkamp TEW: Immunology of DNA-III: Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescent technique. Ann NY Acad Sci 254: 505–515, 1975
- 31 Greenwood M: Epidemiology, Historical and Experi mental. Baltimore, Johns Hopkins Press, 1932
- 32
Cox DR:
Regression models and life tables.
J R Stat Soc [B]
34:
187–220,
1972
10.1111/j.2517-6161.1972.tb00899.x Google Scholar
- 33 US Department of Health and Human Services: Mortality, Part I, Vital Statistics of the US, 1983. Vol. 2. National Center for Health Statistics, Hyattsville, MD, 1987
- 34
Hollingshead AB,
Redlich FC:
Social Class and Mental Illness.
New York,
Wiley Press,
1958
10.1037/10645-000 Google Scholar
- 35 Esdaile JM, Sampalis JS, Lacaille D, Danoff D: The relationship of socioeconomic status to subsequent health status in systemic lupus erythematosus. Arthritis Rheum 31: 423–427, 1988
- 36 Hochberg MC, Sutton JD: Physical disability and psychosocial dysfunction in SLE. J Rheumatol 15: 959–964, 1988
- 37 Rubin LA, Urowitz MB, Gladman DD: Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 216: 87–98, 1985
- 38 Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, Medsger TA Jr, Ziegler G, Klippel JH, Hadler NM, Albert DA, Hess EV, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV: A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 25: 612–617, 1982
- 39 Nived O, Sturfelt G, Wollheim F: Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med 218: 271–287, 1985
- 40 Harris EN, Williams E, Shah DJ, de Ceulaer K: Mortality of Jamaican patients with systemic lupus erythe-matosus. Br J Rheumatol 28: 113–117, 1989
- 41 Fries JF, Holman HR: Systemic Lupus Erythematosus: A Clinical Analysis. Philadelphia, WB Saunders, 1975
- 42 Alger M, Alarcón-Segovia D, Rivero SJ: Hemolytic anemia and thrombocytopenic purpura: two related subsets of systemic lupus erythematosus. J Rheumatol 4: 351–357, 1977
- 43 Miller MH, Urowitz MB, Gladman DD: The significance of thrombocytopenia in systemic lupus erythematosus. Arthritis Rheum 26: 1181–1186, 1983
- 44 Sackett DL: Bias in analytic research. J Chronic Dis 32: 51–63, 1979
